Marion Ressejac-Mercey
Grenoble, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model.
Journal: EBioMedicine
Published: September 04, 2024
Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients.
Journal: Frontiers in immunology
Published: September 01, 2024
PD1 and TIM3 Expression is Associated with Very Early Hepatocellular Carcinoma Recurrence After Percutaneous Thermal Ablation.
Journal: Journal of hepatocellular carcinoma
Published: October 04, 2023
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model.
Journal: International journal of molecular sciences
Published: November 10, 2022
Intracellular accumulation and immunological response of NIR-II polymeric nanoparticles.
Journal: International journal of pharmaceutics
Published: July 06, 2022
Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma.
Journal: Cells
Published: May 27, 2022
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma.
Journal: Cancers
Published: August 27, 2021
Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease.
Journal: Cells
Published: August 09, 2021
Hybrid multimodal contrast agent for multiscale in vivo investigation of neuroinflammation.
Journal: Nanoscale
Published: February 08, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026